CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE4792.15242.4 (+5.33 %)
PREV CLOSE () 4549.75
OPEN PRICE () 4585.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 49427
TODAY'S LOW / HIGH ()4557.80 4810.20
52 WK LOW / HIGH ()3300 4810.2
NSE4790.60243.6 (+5.36 %)
PREV CLOSE() 4547.00
OPEN PRICE () 4570.95
BID PRICE (QTY) 4790.60 (273)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1262221
TODAY'S LOW / HIGH() 4563.85 4810.00
52 WK LOW / HIGH ()3295.3 4810
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300 / 400

Website : www.divislabs.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
17Jul Divi's Laboratories informs about news
Divi's Laboratories has enclosed copies of newspaper publications regard..
20Jun Divi's Laboratories informs about disc
Divi's Laboratories has informed that the Company has sent an email comm..
04Jun Divi's Laboratories trades higher on t
Divi's Laboratories is currently trading at Rs. 4347.10, up by 26.40 poi..
27May Divi's Laboratories reports 68% rise i
Divi's Laboratories has reported results for fourth quarter (Q4) and yea..
27May Divi's Laboratories surges on reportin
Divi's Laboratories is currently trading at Rs. 4279.60, up by 156.85 po..
Financials
in Millions
QTR Mar 24 ANNUAL 24
Net Profit531015760
Gross Profit 7000 21320
Operating Profit 796025110
Net Sales 2259076650
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 28637.90 (2.27%)
M.Cap ( in Cr)
60853.54
Astrazeneca Pharma I (BSE)
 7173.30 (3.40%)
M.Cap ( in Cr)
17933.25
Alkem Laboratories (BSE)
 5295.80 (2.26%)
M.Cap ( in Cr)
63319.23
Hester Biosciences (BSE)
 3206.45 (3.67%)
M.Cap ( in Cr)
2727.68
Torrent Pharma (BSE)
 3191.25 (3.35%)
M.Cap ( in Cr)
108006.40
Shareholding Pattern
PROMOTERS 51.9%
MUTUAL FUNDS/UTI 13.1%
NON-INSTITUTION 10.18%
FI/BANKS/INSURANCE 8.03%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX81332.721292.92 (1.62%)
NIFTY24834.85428.75 (1.76%)
Dow Jones 40589.34654.27 (1.64%)
Nasdaq 17357.88176.16 (1.03%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI